EDGAR Filing Documents for 0001564590-17-015656

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-17-015656

Filing Date

2017-08-04

Accepted

2017-08-04 16:06:16

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	cnat-10q_20170630.htm	10-Q	991843
2	EX-31.1	cnat-ex311_9.htm	EX-31.1	10706
3	EX-32.1	cnat-ex321_10.htm	EX-32.1	6865
	Complete submission text file	0001564590-17-015656.txt		3805489

Data Files

Seq	Description	Document	Type	Size
4	XBRL INSTANCE DOCUMENT	cnat-20170630.xml	EX-101.INS	720390
5	XBRL TAXONOMY EXTENSION SCHEMA	cnat-20170630.xsd	EX-101.SCH	30542
6	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	cnat-20170630_cal.xml	EX-101.CAL	37096
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	cnat-20170630_def.xml	EX-101.DEF	102527
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	cnat-20170630_lab.xml	EX-101.LAB	270232
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	cnat-20170630_pre.xml	EX-101.PRE	205640

Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127

Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600

Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)